MedTrace Logo

Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis.

NCT03667131 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2018-11-14

No results posted yet for this study

Summary

This study evaluates the effect in artery stiffness of enalapril maleate in Rheumatoid Arthritis women patients. Half of participants will receive 5 mg enalapril maleate every 12 hrs, while the other half will receive a placebo.

Conditions

Interventions

DRUG

Enalapril Maleate

Enalapril Maleate 5 mg tablet, every 12 hrs for 90 days.

DRUG

Placebo

Placebo 5 mg tablet, every 12 hrs for 90 days.

Sponsors & Collaborators

  • University of Guadalajara

    lead OTHER

Principal Investigators

  • Monica Vázquez-Del Mercado, MD, PhD · University of Guadalajara

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-13
Primary Completion
2017-12-08
Completion
2018-02-19

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03667131 on ClinicalTrials.gov